You are here: Home » PTI Stories » National » News
Business Standard

Govt taking steps to reduce country's dependence on imports of antibiotic raw materials

Topics
Health Medical Pharma

Press Trust of India  |  New Delhi 

The quantity of raw materials imported for the formulation of antibiotic medicines was reduced to 11,230.50 metric tonne in 2019, as the government has undertaken various steps to promote the production in the country, the Lok Sabha was informed on Tuesday.

As per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 metric tonne (MT) for 2018 and 5,591.44 MT in 2017, Minister of Chemicals & Fertilizers D V Sadananda Gowda said in a reply in the House.

"The policies formulated by Government from time to time are designed to minimize country's dependence on imports and to give fillip to indigenous manufacturing," he added.

In this direction, the government has withdrawn exemption of customs duty on certain categories of bulk drugs/ APIs, which are used in the manufacturing of some of the antibiotics, to provide a level-playing field to domestic manufacturers, Gowda said.

The Department of Pharmaceuticals has formulated a scheme, namely 'Assistance to bulk drug industry for common facility centre', for providing assistance to bulk drug segment in any upcoming bulk drug park promoted by state governments/ state corporations, he added.

"An inter-ministerial task force was also constituted under the chairmanship of the Minister of State of Chemicals and Fertilizers on April 18, 2018 to formulate a roadmap for enhanced production of active pharmaceutical ingredients (APIs) in the country," Gowda said.

Ministry of health and family welfare and CDSCO have also various measures to encourage indigenous manufacturing of drugs, he added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 11 2020. 14:32 IST
RECOMMENDED FOR YOU